Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Income from Continuing Operations (2024 - 2025)

RenovoRx (RNXT) has disclosed Income from Continuing Operations for 2 consecutive years, with 3447000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 35.34% to 3447000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12083000.0 through Dec 2025, down 14.14% year-over-year, with the annual reading at 12083000.0 for FY2025, 14.14% down from the prior year.
  • Income from Continuing Operations hit 3447000.0 in Q4 2025 for RenovoRx, down from 3087000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2439000.0 in Q1 2024 to a low of 3447000.0 in Q4 2025.